Microfluidic Synthesis of Ultrasmall Chitosan/Graphene Quantum Dots Particles for Intranasal Delivery in Alzheimer's Disease Treatment

Abstract

Nanoparticles (NPs) based therapies for Alzheimer's disease (AD) attract interest due to their ability to pass across or bypass the blood‐brain barrier. Chitosan (CS) NPs or graphene quantum dots (GQDs) are promising drug carriers with excellent physicochemical and electrical properties. The current study proposes the combination of CS and GQDs in ultrasmall NP form not as drug carriers but as theranostic agents for AD. The microfluidic‐based synthesis of the CS/GQD NPs with optimized characteristics makes them ideal for transcellular transfer and brain targeting after intranasal (IN) delivery. The NPs have the ability to enter the cytoplasm of C6 glioma cells in vitro and show dose and time‐dependent effects on the viability of the cells. IN administration of the NPs to streptozotocin (STZ) induced AD‐like models lead to a significant number of entrances of the treated rats to the target arm in the radial arm water maze (RAWM) test. It shows the positive effect of the NPs on the memory recovery of the treated rats. The NPs are detectable in the brain via in vivo bioimaging due to GQDs as diagnostic markers. The noncytotoxic NPs localize in the myelinated axons of hippocampal neurons. They do not affect the clearance of amyloid β (Aβ) plaques at intercellular space. Moreover, they showed no positive impact on the enhancement of MAP2 and NeuN expression as markers of neural regeneration. The memory improvement in treated AD rats may be due to neuroprotection via the anti‐inflammation effect and regulation of the brain tissue microenvironment that needs to be studied.

Bio-Nano Synergy in Therapeutic Applications: Drug–Graphene Oxide Nanocomposites for Modulated Acetylcholinesterase Inhibition and Radical Scavenging

“…The incorporation of nanotechnology into medical research marks a significant advancement, especially in the development of innovative therapeutic strategies. − This is particularly visible in the judicious integration of nanomaterials with biological mechanisms, which holds the promise of transforming the way diseases are treated at both the molecular and cellular scales. − The use of two-dimensional (2D) carbon-based materials, such as graphene (G) and/or GO, is increasingly being explored in the context of treating a variety of ailments, including cancer, gastrointestinal infections, and neurodegenerative diseases, like AD and PD, etc. − …”

The Green Synthesis of Reduced Graphene Oxide Using Ellagic Acid: Improving the Contrast-Enhancing Effect of Microbubbles in Ultrasound

“…The ever-increasing interest in graphene-based materials has been focused on biomedical science in recent years. Additionally, inspirational research on graphene derivatives has been focused on wearable electronics, diagnostic tools, drug-delivery carriers and regenerative medicine materials [1][2][3][4]. However, ultrasound medical science gains little attention in graphene research.…”